Yahoo Web Search

Search results

1. jbiomedsci.biomedcentral.com › s12929/020/00695-2Coronavirus vaccine development: from SARS and MERS to COVID-19

   jbiomedsci.biomedcentral.com › s12929/020/00695-2

   • Cached

   Dec 20, 2020 · Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a new type of coronavirus that causes the Coronavirus Disease 2019 (COVID-19), which has been the most challenging pandemic in this century. Considering its high mortality and rapid spread, an effective vaccine is urgently needed to control this pandemic. As a result, the academia, industry, and government sectors are working ...

2. www.nature.com › articles › s41586/020/2798-3SARS-CoV-2 vaccines in development - Nature

   www.nature.com › articles › s41586/020/2798-3

   Vaccine development for SARS-CoV-2 is following an accelerated timeline. Because of knowledge gained from the initial development of vaccines for SARS-CoV and MERS-CoV, the discovery phase was ...

3. pubmed.ncbi.nlm.nih.gov › 33012348SARS-CoV-2 Vaccine Development: Current Status - PubMed

   pubmed.ncbi.nlm.nih.gov › 33012348

   For this study, we scanned the PubMed database from 1963 to 2020 for all publications using the following search terms in various combinations: SARS, MERS, COVID-19, SARS-CoV-2, vaccine, clinical trial, coronavirus, pandemic, and vaccine development. We also did a Web search for these same terms. In addition, we examined the World Health ...

4. pubmed.ncbi.nlm.nih.gov › 33662986Development of SARS-CoV-2 vaccines - PubMed

   pubmed.ncbi.nlm.nih.gov › 33662986

   Results: A total of 141 vaccines in development against SARS-CoV-2 were identified. The technologies used include weakened and inactive viruses, viral vectors, nucleic acids, and proteins. So far, 13 vaccines (9.2%) are under clinical evaluation; only the AZD1222 vaccine is under clinical evaluation Phase II-III.

5. www.cdc.gov › coronavirus › 2019-ncovUnderstanding How COVID-19 Vaccines Work | CDC

   www.cdc.gov › coronavirus › 2019-ncov

   • Cached

   Sep 22, 2023 · New vaccines are first developed in laboratories. Scientists have been working for many years to develop vaccines against coronaviruses, such as those that cause severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). SARS-CoV-2, the virus that causes COVID-19, is related to these other coronaviruses.

6. www.ncbi.nlm.nih.gov › pmc › articlesSARS-CoV-2 vaccines: a triumph of science and collaboration

   www.ncbi.nlm.nih.gov › pmc › articles

   May 5, 2021 · The massive scale of SARS-CoV-2 infection worldwide and the enormous death toll called for a different approach. In May 2020, the US government established Operation Warp Speed, a public-private partnership to accelerate the development, production, and distribution of COVID-19 vaccines, therapeutics, and diagnostics.

7. pubmed.ncbi.nlm.nih.gov › 33293238SARS-CoV-2: Targeted managements and vaccine development

   pubmed.ncbi.nlm.nih.gov › 33293238

   COVID-19 Vaccines. Viral Vaccines. ACE2 protein, human. Angiotensin-Converting Enzyme 2. Infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) results in diverse outcomes. The symptoms appear to be more severe in males older than 65 and people with underlying health conditions; approximately one in five individuals ...